The nonprofit teaching hospital Holy Cross Health has partnered with the COPD Foundation to open a pilot program to…
Articles by Joana Carvalho, PhD
A new Alexa healthcare skill, called the Emmi Care Plan, provides a voice service that allows patients to easily…
Older patients with chronic obstructive pulmonary disease (COPD) taking oral, synthetically-made cannabinoids — medications based on compounds found…
Verona Pharma has launched two Phase 3 trials to assess the safety and effectiveness of ensifentrine, its investigational…
Chronic obstructive pulmonary disease (COPD) is more prevalent than previously thought and associated with a mortality rate that is…
PR1P, a small peptide able to increase the activity of vascular endothelial growth factor (VEGF) in cells lining the…
Breztri Aerosphere, AstraZeneca’s triple combination therapy for chronic obstructive pulmonary disease (COPD), significantly reduces the frequency…
Remestemcel-L, Mesoblast’s lead candidate stem cell therapy for inflammatory diseases, improves lung function and exercise capacity in people…
Chronic obstructive pulmonary disease (COPD) is linked to a higher risk of lung cancer in people who never…
Duaklir (aclidinium bromide and formoterol fumarate), a long-term maintenance treatment for chronic obstructive pulmonary disease (COPD),…